Pharmacokinetic evaluation of indinavir and indinavir/ritonavir-containing antiretroviral regimens in a clinical setting

被引：4

作者：

Boffito, M ^{[1
]}

Bonora, S

Raiteri, R

Reynolds, HE

Hoggard, PG

Sinicco, A

Back, DJ

Di Perri, G

机构：

[1] Univ Liverpool, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England

[2] Univ Liverpool, Dept Pharmacol, Turin, Italy

来源：

THERAPEUTIC DRUG MONITORING | 2002年 / 24卷 / 04期

关键词：

D O I：

10.1097/00007691-200208000-00021

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：574 / 576

页数：3

共 16 条

[1] The role of therapeutic drug monitoring in treatment of HIV infection [J].

Back, DJ ;

Khoo, SH ;

Gibbons, SE ;

Merry, C .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (04) :301-308

[2] Pros and cons of therapeutic drug monitoring of antiretroviral agents [J].

Burger, DM ;

Aarnoutse, RE ;

Hugen, PWH .

CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (01) :17-22

[3] A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy [J].

Burger, DM ;

Hugen, PWH ;

Aarnoutse, RE ;

Dieleman, JP ;

Prins, JM ;

van der Poll, T ;

ten Veen, JH ;

Mulder, JW ;

Meenhorst, PL ;

Blok, WL ;

van der Meer, JTM ;

Reiss, P ;

Lange, JMA .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (03) :218-224

[4]

BURGER DM, 2001, 2 INT WORKSH CLIN PH

[5] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].

Carpenter, CCJ ;

Cooper, DA ;

Fischl, MA ;

Gatell, JM ;

Gazzard, BG ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schechter, M ;

Schooley, RT ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390

[6]

Casado J L, 2000, HIV Clin Trials, V1, P13

[7] Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy [J].

Condra, JH ;

Petropoulos, CJ ;

Ziermann, R ;

Schleif, WA ;

Shivaprakash, M ;

Emini, EA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :758-765

[8] Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients [J].

Dieleman, JP ;

Gyssens, IC ;

van der Ende, ME ;

de Marie, S ;

Burger, DM .

AIDS, 1999, 13 (04) :473-478

[9] Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study [J].

Durant, J ;

Clevenbergh, P ;

Garraffo, R ;

Halfon, P ;

Icard, S ;

Del Giudice, P ;

Montagne, N ;

Schapiro, JM ;

Dellamonica, P .

AIDS, 2000, 14 (10) :1333-1339

[10] The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring [J].

Gatti, G ;

Di Biagio, A ;

Casazza, R ;

De Pascalis, C ;

Bassetti, M ;

Cruciani, M ;

Vella, S ;

Bassetti, D .

AIDS, 1999, 13 (15) :2083-2089

← 1 2 →